Clinical Trial Update: A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 study in previously untreated chronic lymphocytic leukemia (excluding 17p deletion) evaluating debulking regimens before starting venetoclax-based com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Phase 3 | Status: COMPLETED | Results posted: 2022-11-03